#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Deficit of GATA-2 transcription factor: new immunodeficiency syndrome with broad phenotype. First patients diagnosed in the Czech Republic and review of the literature


Authors: A. Janda 1;  E. Mejstříková 2;  U. Salzer 1;  J. Grimová 3;  T. Svobodová 4;  M. Suková 2;  M. Nováková 2;  P. Hubáček 2,9;  Z. Zemanová 5;  J. Čermák 6;  Z. Černá 7;  A. Vítek 6;  A. Šedivá 8;  O. Hrušák 2;  J. Starý 2
Authors‘ workplace: Centre of Chronic Immunodeficiency (CCI), University Medical Centre and University of Freiburg, Freiburg im Breisgau, Německo 1;  Klinika dětské hematologie a onkologie UK 2. LF a FN Motol, Prahapřednosta prof. MUDr. J. Starý, DrSc. 2;  Onkologická klinika UK 1. LF a Fakultní Thomayerovy nemocnice, Prahapřednosta MUDr. T. Buchler, Ph. D. 3;  Pediatrická klinika UK 2. LF a FN Motol, Prahapřednosta prof. MUDr. J. Lebl, CSc. 4;  Ústav lékařské biochemie a laboratorní diagnostiky UK 1. LF a VFN, Prahapřednosta prof. MUDr. T. Zima, DrSc., MBA 5;  Ústav hematologie a krevní transfuze, Prahaředitel prof. MUDr. M. Trněný, CSc. 6;  Dětská klinika Lékařské fakulty Univerzity Karlovy, Plzeňpřednosta doc. MUDr. J. Kobr, Ph. D. 7;  Ústav imunologie UK 2. LF a FN Motol, Prahapřednostka prof. MUDr. J. Bartůňková, DrSc., MBA 8;  Ústav lékařské mikrobiologie UK 2. LF a FN Motol, Prahapřednosta doc. MUDr. P. Dřevínek, Ph. D. 9
Published in: Čes-slov Pediat 2013; 68 (2): 101-112.
Category: Case Report

Overview

Defects in the zinc-finger transcription factor GATA-2 gene have been recently identified in variable phenotypes associated with myeloid malignancies - myelodysplastic syndrome and acute myeloid leukaemia (MDS/AML): DCML (dendritic cell, monocyte, B-lymphocyte and NK-lymphocyte) deficiency or MonoMAC syndrome (monocytopenia with Mycobaterium avium complex infections), Emberger syndrome (early onset primary lymphoedema, multiple warts, sensorineural deafness, dysmorphism); and familial MDS/AML with no additional known phenotype.

In the Czech Republic there have been 2 patients diagnosed with GATA-2 deficiency so far. The first patient was investigated at the age of 12 years for recurrent urinary tract infections, aphtous stomatitis, herpetic skin infections and bronchial asthma; leukopenia, mild macrocytic anaemia and markedly low number of B lymphocytes with normal immunoglobulin levels were found. In the following 10 years bicytopenia progressed into a hypoplastic MDS. The girl underwent successful transplantation of haematopoietic stem cells from her HLA-identical healthy sister. Retrospectively, a heterozygous mutation (c.1187 G>A, p.R396Q) in GATA-2 has been identified. The second patient is 17 year-old boy investigated for an advanced interstitial pulmonary process with cystic remodelling of pulmonary parenchyma accompanied by signs of vasculitis. Suspicion of GATA-2 genetic defect was based on profound monocytopenia and B-cell lymphopenia. By molecular genetic analysis of GATA-2 heterozygous mutation (c.1081 C>T, p.R361C) was revealed.

Our experience corresponds with the published data on the broad phenotypic variability in patients with GATA-2 mutations. Establishment of the diagnosis of GATA-2 deficiency should lead to closer follow-up of the affected individuals and earlier allogeneic haematopoietic stem cell transplantation in case of clonal progression (MDS/AML).

Key words:
primary immunodeficiency, GATA-2 deficiency, MonoMAC, dendritic cell, monocyte, B lymphocyte, and natural killer lymphocyte deficiency (DCML), Emberger syndrome; pulmonary alveolar proteinosis, haematopoietic stem cell transplantation


Sources

1. Al-Herz W, et al. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol 2011; 2: 54.

2. Bresnick EH, et al. Master regulatory GATA transcrip-tion factors: mechanistic principles and emerging links to hematologic malignancies. Nucleic Acids Res 2012; 40 (13): 5819–5831.

3. Rodrigues NP, et al. GATA-2 mediated regulation of normal hematopoietic stem/progenitor cell function, myelodysplasia and myeloid leukemia. Int J Biochem Cell Biol 2012; 44 (3): 457–460.

4. Hahn CN, et al. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat Genet 2011; 43 (10): 1012–1017.

5. Hsu AP, et al. Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood 2011; 118 (10): 2653–2655.

6. Dickinson RE, et al. Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency. Blood 2011; 118 (10): 2656–2658.

7. Bigley V, Collin M. Dendritic cell, monocyte, B and NK lymphoid deficiency defines the lost lineages of a new GATA-2 dependent myelodysplastic syndrome. Haematologica 2011; 96 (8): 1081–1083.

8. Ostergaard P, et al. Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Nat Genet 2011; 43 (10): 929–931.

9. Kazenwadel J, et al. Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature. Blood 2012; 119 (5): 1283–1291.

10. Vinh DC, et al. Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia. Blood 2010; 115 (8): 1519–1529.

11. Bigley V, et al. The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency. J Exp Med 2011; 208 (2): 227–234.

12. Calvo KR, et al. Myelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implications. Haematologica 2011; 96 (8): 1221–1225.

13. Zhang SJ, Shi JY, Li JY. GATA-2 L359 V mutation is exclusively associated with CML progression but not other hematological malignancies and GATA-2 P250A is a novel single nucleotide polymorphism. Leuk Res 2009; 33 (8): 1141–1143.

14. Lasbury ME, et al. Effect of transcription factor GATA-2 on phagocytic activity of alveolar macrophages from Pneumocystis carinii-infected hosts. Infect Immun 2003; 71 (9): 4943–4952.

15. Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med 2002; 166 (2): 215–235.

16. Dirksen U, et al. Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression. J Clin Invest 1997; 100 (9): 2211–2217.

17. Inoue Y, et al. Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan. Am J Respir Crit Care Med 2008; 177 (7): 752–762.

18. Bert AG, et al. A modular enhancer is differentially regulated by GATA and NFAT elements that direct different tissue-specific patterns of nucleosome positioning and inducible chromatin remodeling. Mol Cell Biol 2007; 27 (8): 2870–2885.

19. German Z, et al. Molecular basis of cell-specific endothelial nitric-oxide synthase expression in airway epithelium. J Biol Chem 2000; 275 (11): 8183–8189.

20. Liew E, Owen C. Familial myelodysplastic syndromes: a review of the literature. Haematologica 2011; 96 (10): 1536–1542.

21. Bodor C, et al. Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival. Haematologica 2012; 97 (6): 890–894.

22. Cuellar-Rodriguez J, et al. Successful allogeneic hematopoietic stem cell transplantation for GATA2 deficiency. Blood 2011; 118 (13): 3715–3720.

23. Rosenzweig SD, Holland SM. Defects in the interferon-gamma and interleukin-12 pathways. Immunol Rev 2005; 203: 38–47.

24. Hambleton S, et al. IRF8 mutations and human dendritic-cell immunodeficiency. N Engl J Med 2011; 365 (2): 127–138.

25. Chatila TA, et al. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity – allergic disregulation syndrome. J Clin Invest 2000; 106 (12): R75–81.

26. Holland SM, et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med 2007; 357 (16): 1608–1619.

27. Liu L, et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med 2011; 208 (8): 1635–1648.

Labels
Neonatology Paediatrics General practitioner for children and adolescents
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#